Search results for: Vaccines
Filter search results
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…2014. Accessed February 27, 2024. https://www.ohe.org/news/orphan-drugs-policies-suitable-case-treatment/ Kettler H, Towse A. Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty – OHE. OHE – Leading intellectual…
New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year
16 December 2024
…key areas of work impacted during a presenteeism day related to error rate and quality (29%), creativity (29%), decision making (27%) and communication (26%). Investments in prevention, including vaccines, hygiene,…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…for the purchase of COVID vaccines. This modelling work with CGD’s Rachel Bonnifield has been adopted and updated by the Alliance for Reducing Microbial Resistance to support EU policy making….
Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised….
Policy, Organisation and Incentives in Health Systems
Policy, Organisation and Incentives in Health Systems Development of effective health system policy requires an understanding of organisational structures, funding streams, and incentive mechanisms that shape how healthcare interventions and…
Measuring Value with Pharmacoeconomics
26 May 2011
…the value of drugs, vaccines and other health technologies. CEA usually is applied within a broader framework of health technology assessment (HTA), whereby the technology is assessed for use and/or…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
…regulatory support for pre-competitive consortia Hybrid Orphan drug legislation Vaccines and drugs to counter chemical, biological, radiological and nuclear (CBRN) threats, including Project BioShield The authors argue that push incentives…
Presentations from ISPOR and HTAi 2018
12 July 2018
…HTA in Incentivising New Drugs and Vaccines to Tackle AMR from Office of Health Economics Optimizing the Use of RWE in HTA: the ICER Membership Summit 2017 from Office…
Generating Preference-based Values for the EQ-5D-Y to Support Its Use in HTA
31 January 2019
…S. and Devlin, N., 2016. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review. Value in Health, 19, pp.255-266. DOI. Kreimeier, S., Oppe, M.,…